1. Overview of the Hatch–Waxman Act and its impact on the drug development process;Mossinghoff;Food Drug Law J.,1999
2. COX-2 inhibition: what we learned – a controversial update on safety data;Katz;Pain Med.,2013
3. GSK to discontinue manufacture and sale of the BEXXAR® therapeutic regimen (tositumomab and iodine I 131 tositumomab);GlaxoSmithKline Press release,2014
4. Historical milestones and discoveries that shaped the toxicology sciences;Hayes;EXS,2009
5. Aspirin: The Remarkable Story of a Wonder Drug,2008